These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21824900)

  • 1. Altered urinary excretion of aquaporin 2 in IgA nephropathy.
    Rocchetti MT; Tamma G; Lasorsa D; Suriano IV; D'Apollo A; Papale M; Mastrofrancesco L; Grandaliano G; Svelto M; Valenti G; Gesualdo L; Di Paolo S
    Eur J Endocrinol; 2011 Oct; 165(4):657-64. PubMed ID: 21824900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
    Urushihara M; Nagai T; Kinoshita Y; Nishiyama S; Suga K; Ozaki N; Jamba A; Kondo S; Kobori H; Kagami S
    Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    Zittema D; Casteleijn NF; Bakker SJ; Boesten LS; Duit AA; Franssen CF; Gaillard CA; Gansevoort RT
    PLoS One; 2017; 12(1):e0169263. PubMed ID: 28081165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy.
    Rocchetti MT; Centra M; Papale M; Bortone G; Palermo C; Centonze D; Ranieri E; Di Paolo S; Gesualdo L
    Proteomics; 2008 Jan; 8(1):206-16. PubMed ID: 18095357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG; Song SB; Lee SH; Moon JY; Jeong KH; Lee TW; Ihm CG
    Clin Exp Nephrol; 2011 Oct; 15(5):720-726. PubMed ID: 21695414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
    Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
    Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients.
    Jang HR; Kim SM; Lee YJ; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Ann Med; 2012 Aug; 44(5):448-57. PubMed ID: 21366514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
    Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
    Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Node K
    Am J Hypertens; 2007 Nov; 20(11):1195-201. PubMed ID: 17954367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of urinary angiotensinogen and renin as potential biomarkers in patients with overt proteinuria.
    Jang HR; Jeon J; Park JH; Lee JE; Huh W; Oh HY; Kim YG
    Transl Res; 2014 Nov; 164(5):400-10. PubMed ID: 24929205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
    Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
    Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.